In breast cancer, RET alterations occur in ~1.2% of cases, including CCDC6–RET, NCOA4–RET, RASGEF1A–RET, and ZNF485–RET fusions, or tandem duplications of exons 12–19 [22]. Here, RET is linked to breast cancer.